Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2007 | 07-2007 | 04-2007 | 01-2007 | 10-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,232 | -13,260 | -9,930 | -6,098 | -1,246 |
| Depreciation Amortization | 449 | 1,189 | 795 | 528 | 271 |
| Income taxes - deferred | -166 | -178 | N/A | N/A | N/A |
| Accounts receivable | -1,317 | -4,155 | -4,599 | -1,772 | -559 |
| Accounts payable and accrued liabilities | -382 | 429 | 291 | -319 | 88 |
| Other Working Capital | -1,714 | 1,432 | -2,225 | 865 | 2,022 |
| Other Operating Activity | 3,191 | 10,777 | 9,715 | 5,065 | 1,764 |
| Operating Cash Flow | $-1,171 | $-3,766 | $-5,953 | $-1,731 | $2,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -402 | -1,448 | -1,069 | -310 | -158 |
| Net Acquisitions | -37 | -16,888 | N/A | N/A | N/A |
| Other Investing Activity | -120 | -89 | -98 | -120 | -155 |
| Investing Cash Flow | $-559 | $-18,425 | $-1,167 | $-430 | $-313 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 349 | 57,497 | 57,290 | 43,223 | 79 |
| Financing Cash Flow | $349 | $57,497 | $57,290 | $43,223 | $79 |
| Exchange Rate Effect | 18 | -11 | N/A | N/A | N/A |
| Beginning Cash Position | 105,149 | 69,854 | 69,854 | 69,854 | 69,854 |
| End Cash Position | 103,786 | 105,149 | 120,024 | 110,916 | 71,960 |
| Net Cash Flow | $-1,363 | $35,295 | $50,170 | $41,062 | $2,106 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,171 | -3,766 | -5,953 | -1,731 | 2,340 |
| Capital Expenditure | -402 | -1,448 | -1,069 | -310 | -158 |
| Free Cash Flow | -1,573 | -5,214 | -7,022 | -2,041 | 2,182 |